Literature DB >> 34274258

RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways.

Xiao-Chen Xu1, Shuai He1, Ya-Qing Zhou1, Chu-Jun Liu1, Shu-Qiang Liu1, Wan Peng1, Yu-Xiang Liu1, Pan-Pan Wei1, Jin-Xin Bei2, Chun-Ling Luo3.   

Abstract

RNA binding motif proteins (RBMs) have been widely implicated in the tumorigenesis of multiple human cancers but scarcely studied in nasopharyngeal carcinoma (NPC). Here, we compare the mRNA levels of 29 RBMs between 87 NPC and 10 control samples. We find that RBM47 is frequently upregulated in NPC specimens, and its high expression is associated with the poor prognosis of patients with NPC. Biological experiments show that RBM47 plays an oncogenic role in NPC cells. Mechanically, RBM47 binds to the promoter and regulates the transcription of BCAT1, and its overexpression partially rescues the inhibitory effects of RBM47-knockdown on NPC cells. Moreover, transcriptome analysis reveals that RBM47 regulates alternative splicing of pre-mRNA, including those cancer-related, to a large extent in NPC cells. Furthermore, RBM47 binds to hnRNPM and cooperatively regulates multiple splicing events in NPC cells. In addition, we find that knockdown of hnRNPM inhibits proliferation and migration of NPC cells. Our study, taken together, shows that RBM47 promotes the progression of NPC through multiple pathways, acting as a transcriptional factor and a modulator of alternative splicing in cooperation with hnRNPM. Our study also highlights that RBM47 and hnRNPM could be prognostic factors and potential therapeutic targets for NPC.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alternative splicing; BCAT1; Nasopharyngeal carcinoma (NPC); RBM47; hnRNPM

Mesh:

Year:  2021        PMID: 34274258     DOI: 10.1016/j.jgg.2021.05.006

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  1 in total

1.  RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator.

Authors:  Tao Guo; Ke You; Xi Chen; Yuqi Sun; Ying Wu; Ping Wu; Yingying Jiang
Journal:  Cell Death Discov       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.